FDA Approves Colcrys (colchicine, USP) for Prevention of Gout Flares
Posted 2 days 4 hours ago by Drugs.com
New Colchicine Formulation Significantly Reduces Side Effects, Maintains Full Efficacy; Now Indicated for Both Prophylaxis and Treatment of Gout Flares
PHILADELPHIA, Oct. 19 /PRNewswire/ – URL Pharma, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare. Read more...
Related support groups: Gout, Gout -- Acute, Gout -- Prophylaxis, Colchicine
More Vitamin C May Mean Less Chance of Gout
Posted 3+ months ago by Drugs.com
MONDAY, March 9 – Consuming more vitamin C may help reduce a man's risk of gout, according to researchers who studied almost 47,000 men over a 20-year span.
During that time, more than 1,300 of the men developed gout. Compared with those whose vitamin C intake through food and supplements was less than 250 milligrams a day, the risk for gout was 17 percent lower among men with a daily intake of 500 to 999 milligrams, 34 percent lower for those who took in 1,000 to 1,499 milligrams, and 45 percent lower with a daily intake of 1,500 milligrams or more.
For every 500 mg increase in vitamin C intake, the risk for gout fell 17 percent, the researchers calculated. Read more...
Related support groups: Ascor L 500, Gout, Gout -- Acute, Gout -- Prophylaxis
Uloric Approved for Gout
Posted 3+ months ago by Drugs.com
MONDAY, Feb. 16 – Takeda Pharmaceuticals' Uloric (febuxostat) has been approved by the U.S. Food and Drug Administration to treat gout, a painful condition characterized by elevated levels of uric acid that can build up in the blood, joints and soft tissue.
Uloric is the first new treatment option in more than four decades for gout, a chronic condition affecting more than 5 million Americans, the Japanese drug maker said in a news release. It's the most common inflammatory arthritis in men 40 and older. Read more...
Related support groups: Gout, Gout -- Acute, Gout -- Prophylaxis
Drug Improves Outcomes for Gout Patients
Posted 3+ months ago by Drugs.com
SUNDAY, Oct. 26 – The drug pegloticase (Puricase) may help gout patients who've had no luck with other treatments, according to researchers who studied 212 patients who'd run out of treatment options.
They were randomly assigned to receive six months of intravenous treatment with either pegloticase or a placebo. One group of patients received 8 milligrams of pegloticase every two weeks, another group received 8 milligrams of pegloticase every four weeks, and a third group received the placebo. Read more...
Related support groups: Gout
New Drug Helps Relieve Gout
Posted 3+ months ago by Drugs.com
WEDNESDAY, Sept. 3 – An experimental gout drug called pegloticase lowered levels of uric acid in the blood to target levels within a few hours in most patients.
That's the conclusion of a study by researchers at Duke University Medical Center and Savient Pharmaceuticals, the company that's developing the drug.
The phase II clinical trial included 41 patients randomly selected to receive either four or eight milligrams of pegloticase every two weeks, or eight or 12 milligrams every four weeks, for a 12- or 14-week period. The treatment is an infusion that takes about two hours. Read more...
Related support groups: Gout
Ask a Question
You may also be interested in...
Related Condition Support Groups
Gout -- Acute, Gouty Arthritis, Gout -- Prophylaxis, Pseudogout, Gouty Nephropathy
Related Drug Support Groups
allopurinol, Zyloprim, Benemid, probenecid, Aloprim, Lopurin, febuxostat
